Hybridomas producing human monoclonal antibodies (MAbs) against human cytomegalovirus (CMV) were generated by fusion of human spleen cells and mouse myeloma cells. Two of the six MAbs obtained neutralized viral infectivity even at concentrations lower than 1 μg/ml. One MAb required complement for neutralization but the other did not. Both MAbs recognized viral proteins of Mr 130000 and 55000. Furthermore, these neutralizing MAbs bound to the surface membrane of CMV- infected cells. These results suggest that human MAbs may provide a new means of passive immunization against CMV infection in humans.
BurnettK. G.,
MasuhoY.,
HernandezR.,
MaedaT.,
KingM. P.,
MartinisJ.1985; Human monoclonal antibodies to breast tumor cells. In Monoclonal Antibodies: Diagnosis and Therapeutic Use in Tumor and Transplantation pp. 47–61ChatterjeeS. N.
Edited by Littleton: PSG Publishing Co. Ltd;
CondieR. M.,
O’ReilleyR. J.1984; Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients. American Journal of Medicine 76(3A):134–141
KetteringJ. D.,
SchmidtN. j.,
GallsD.,
LennetteE. H.1977; Anti-complement immunofluorescent test for antibodies to human cytomegalovirus. Journal of Clinical Microbiology 6:627–632
MasuhoY.,
SuganoT.,
MatsumotoY.,
SawadaS.,
TomibeK.1986; Generation of hybridomas producing human monoclonal antibodies against herpes simplex virus after in vitro stimulation. Biochemical and Biophysical Research Communications 135:495–500
MatsumotoY.,
SuganoT.,
MiyamotoC.,
MasuhoY.1986; Establishment of hybridomas producing human monoclonal antibodies against human cytomegalovirus. Biochemical and Biophysical Research Communications 137:273–280
MeyersJ. D.,
FlournoyN.,
WadeJ. C.,
HackmanR. C.,
McdougallJ. K.,
NeimanP. E.,
ThomasE. D.1983; Biology of interstitial pneumonia after marrow transplantation. In Recent Advances in Bone Marrow Transplantation pp. 405–423GaleR. P.
Edited by New York: Alan R. Liss Inc;
QuinnanG. V.,
RookA. H.,
FrederickW. R.,
ManischewitzJ. F.,
EpsteinJ. S.,
SiegelJ.,
MasurH.,
MacherA. M.,
MitchellC.,
ArmstrongG.,
DjeuJ. Y.1984; Prevalence, clinical manifestations, and immunology of herpesvirus infections in the acquired immunodeficiency syndrome. Annals of the New York Academy of Sciences 437:200–206
RasmussenL. E.,
NelsonR. M.,
KelsallN. D.,
MeriganT. C.1984; Murine monoclonal antibody to a single protein neutralizes the infecti vity of human cytomegalovirus. Proceedings of the National Academy of Sciences, U.S.A 81:876–880
RasmussenL.,
MullenaxJ.,
NelsonR.,
MeriganT. C.1985; Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus. Journal of Virology 55:274–280
RedmondM. J.,
Leyritz-WillsM.,
WingerL.,
ScrabaD. G.1986; The selection and characterization of human monoclonal antibodies to human cytomegalovirus. Journal of Virological Methods 14:9–24
SawadaS.,
KawamuraT.,
MasuhoY.,
TomibeK.1985; Characterization of a human monoclonal antibody to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa
. Journal of Infectious Diseases 152:965–970